| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 06/06/2013 | CA2850593A1 2-phenylaminopyrimidine derivatives as kinase lrrk2 modulators for the treatment of parkinson's disease |
| 06/05/2013 | EP2598498A1 Hetero-bicyclic derivatives as hcv inhibitors |
| 06/05/2013 | EP2598496A1 Novel process for the preparation of asenapine |
| 06/05/2013 | CN103131206A Pyrazolopyridine benzo coumarin dye derivative and synthetic method and purpose thereof |
| 06/05/2013 | CN103130814A Two types of 9-nitro comptothecin novel crystal forms and preparation method thereof |
| 06/05/2013 | CN103130804A N,N'-dialkyl-14H-benzo[4,5]isoquinolino[2,1-a]perimidine-14-one-3,4,10,11-diimide compound and preparation method and application thereof |
| 06/05/2013 | CN103130759A Goniothalamus cheliesis vitamin derivative and application of goniothalamus cheliesis vitamin derivative in pharmacy |
| 06/04/2013 | US8455511 Pyrrolopyridine derivatives substituted with cyclic amino group |
| 06/04/2013 | CA2545660C Heterocyclic inhibitors of mek and methods of use thereof |
| 06/04/2013 | CA2545659C Bicyclic inhibitors of mek |
| 06/01/2013 | CA2760174A1 Protein kinase inhibitors and uses thereof |
| 05/30/2013 | WO2013078244A1 Carboxy x rhodamine analogs |
| 05/30/2013 | WO2013077362A1 Aromatic heterocyclic derivative, material for organic electroluminescent element, and organic electroluminescent element |
| 05/30/2013 | WO2013077345A1 Organic electroluminescent element, and light emitting device, display device and lighting device each using organic electroluminescent element |
| 05/30/2013 | WO2013077344A1 Organic electroluminescent element, material for organic electroluminescent element, light emitting device, display device and lighting device each using said element, and compound used for said element |
| 05/30/2013 | WO2013075621A1 Norepinephrine and selective serotonin receptor blocker and use thereof |
| 05/30/2013 | WO2013013068A4 Embodiments of a probe and method for targeting nucleic acids |
| 05/30/2013 | US20130137675 Heterocyclic compound and use thereof |
| 05/30/2013 | US20130137661 Gonadotropin Releasing Hormone Receptor Antagonist, Preparation Method Thereof And Pharmaceutical Composition Comprising The Same |
| 05/29/2013 | EP2597088A1 P2x4 receptor antagonist |
| 05/29/2013 | EP2597086A1 Cyclic n,n'-diarylthioureas and n,n'-diarylureas as androgen receptor antagonists, anti-cancer agent, method for producing and using same |
| 05/29/2013 | EP2595989A1 Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels |
| 05/29/2013 | EP2595988A1 Tricyclic compounds and methds of making and using same |
| 05/29/2013 | EP2595483A1 Novel pyrrolidine derived beta 3 adrenergic receptor agonists |
| 05/29/2013 | CN103122362A Method of extracting CPT (camptothecin) from Mappia foetida by microorganism solid-state fermentation technology |
| 05/29/2013 | CN102206180B Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors |
| 05/29/2013 | CN101730701B Hydrated crystalline esters of camptothecin for the treatment of cancer |
| 05/29/2013 | CN101693714B Spirocyclic cyclohexane derivatives |
| 05/29/2013 | CN101407514B Tiotropium salts, tiotropium salts pharmaceutical formulations and uses thereof |
| 05/28/2013 | US8450360 Process for preparing dithiine-tetracarboximides |
| 05/28/2013 | US8450358 Enantiomers of spiro-oxindole compounds and their uses as therapeutic agents |
| 05/28/2013 | US8450343 Gamma secretase modulators |
| 05/28/2013 | US8450341 Substituted indolin-2-one derivatives and their use as P38 mitogen-activated kinase inhibitors |
| 05/28/2013 | US8450340 1H-pyrazolo[3,4-b]pyridines and therapeutic uses thereof |
| 05/28/2013 | CA2683768C Method of synthesizing camptothecin-relating compounds |
| 05/28/2013 | CA2650698C Copolyvidone-containing preparation |
| 05/28/2013 | CA2576765C Pyridine methylene azolidinones and use thereof phosphoinositide inhibitors |
| 05/28/2013 | CA2547887C Protein modifier production inhibitor |
| 05/28/2013 | CA2530886C Dual nk1/nk3 antagonists for treating schizophrenia |
| 05/28/2013 | CA2381468C Percutaneous absorption preparations containing melatonin receptor agonist for percutaneous treatment of sleep disorders |
| 05/23/2013 | WO2013075029A1 Condensed imidazolylimidazoles as antiviral compounds |
| 05/23/2013 | WO2013074633A1 Uracil derivatives as axl and c-met kinase inhibitors |
| 05/23/2013 | WO2013073896A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 05/23/2013 | WO2013072694A1 Thieno- and furo - pyrimidines and pyridines, useful as potassium channel inhibitors |
| 05/23/2013 | WO2013071697A1 Aminoquinazoline derivatives and their salts and methods of use |
| 05/23/2013 | WO2013024492A3 A process for the preparation of asenapine and novel salts thereof |
| 05/23/2013 | US20130131338 Substituted diketopiperazines as oxytocin antagonists |
| 05/23/2013 | US20130131070 1-Aryl or 1- Heteroaryl-Pyrido(B)indoles and Uses Thereof |
| 05/23/2013 | US20130131055 Furopyridinyl-substituted 1,4-dihydropyridine derivatives and methods of use thereof |
| 05/23/2013 | US20130131041 Spirocyclic compounds |
| 05/23/2013 | CA2855346A1 Thieno- and furo - pyrimidines and pyridines, useful as potassium channel inhibitors |
| 05/23/2013 | CA2852697A1 Uracil derivatives as axl and c-met kinase inhibitors |
| 05/23/2013 | CA2851151A1 Aminoquinazoline derivatives and their salts and methods of use |
| 05/23/2013 | CA2815082A1 Antiviral compounds |
| 05/22/2013 | EP2594267A1 Protective Agent for Retinal Nerve or Optic Nerve |
| 05/22/2013 | EP2593462A1 NOVEL FUSED HETEROCYCLIC DERIVATIVES USEFUL AS c-MET TYROSINE KINASE INHIBITORS |
| 05/22/2013 | CN103119028A 1,2,4-Triazolone Derivative |
| 05/22/2013 | CN103113381A Serial water-soluble hydroxycamptothecine naphthenic amino alcohol derivative and preparation method and use thereof |
| 05/22/2013 | CN103113380A Rhodamine derivative and preparation method and application thereof |
| 05/22/2013 | CN103113379A Synthetic process for asenapine maleate |
| 05/22/2013 | CN103113340A Genistein alkylamine compound, preparation method and use of genistein alkylamine compound |
| 05/22/2013 | CN103113337A Preparation method of dibenzofuran derivative |
| 05/22/2013 | CN102026998B Spirocyclic derivatives as histone deacetylase inhibitors |
| 05/22/2013 | CN101479250B Tetrazole-substituted arylamides |
| 05/22/2013 | CN101365446B Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices |
| 05/21/2013 | US8445696 Synthetic methods for spiro-oxindole compounds |
| 05/21/2013 | US8445509 Fused heterocyclic derivatives and use thereof |
| 05/21/2013 | US8445503 Inhibitors of polo-like kinase |
| 05/21/2013 | US8445482 Thieno- and furo-pyrimidine modulators of the histamine H4 receptor |
| 05/21/2013 | US8445477 Azetidinyl diamides as monoacylglycerol lipase inhibitors |
| 05/16/2013 | WO2013069939A1 Compound for organic electronic element, organic electronic element including the same, electronic device thereof |
| 05/16/2013 | WO2013069771A1 Anthranilic acid derivative and noxious organism control agent |
| 05/16/2013 | WO2013068470A1 Inhibitors of phosphodiesterase type 10a |
| 05/16/2013 | WO2013068328A1 Bicyclo [2.2.2] octan-1-ylcarboxylic acid compounds as dgat-1 inhibitors |
| 05/16/2013 | WO2013067882A1 Water-soluble vitamin e derivative modified fat-soluble anti-cancer drug compound and formulation, preparation method and use thereof |
| 05/16/2013 | WO2013067881A1 Water-soluble vitamin e derivative-modified amphiphilic anticancer medicament compound and preparation, method for preparing the compound, and application thereof |
| 05/16/2013 | US20130123324 Crystalline (1r, 4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine |
| 05/16/2013 | US20130123241 Novel ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments |
| 05/16/2013 | US20130123236 Substituted benzylspiroindolin-2-one analogs as positive allosteric modulators of the muscarinic acetylcholine receptor m1 |
| 05/16/2013 | US20130123235 Tricyclic Compounds and Methods of Making and Using Same |
| 05/16/2013 | US20130123234 Aryl- or Heteroaryl-Substituted Benzene Compounds |
| 05/16/2013 | US20130121986 Nitrogenated derivatives of pancratistatin |
| 05/16/2013 | CA2855372A1 Acc inhibitors and uses thereof |
| 05/16/2013 | CA2855180A1 Trolox derivative-modified fat-soluble anti-cancer pharmaceutical compounds, preparations, preparing methods and use thereof |
| 05/16/2013 | CA2852604A1 Inhibitors of phosphodiesterase type 10a |
| 05/15/2013 | EP2592070A2 Tetrazole-substituted arylamides |
| 05/15/2013 | EP2590985A1 Novel spiroheterocyclic compounds as mglu5 antagonists |
| 05/15/2013 | EP2590984A1 Anellated pyridine compounds |
| 05/15/2013 | EP2590980A1 Fused heterocyclic derivatives as s1p modulators |
| 05/15/2013 | EP2590968A1 Cyclic ether compounds useful as kinase inhibitors |
| 05/15/2013 | EP2590955A1 Spiro-cyclic amine derivatives as s1p modulators |
| 05/15/2013 | EP2590953A1 Tetrazole compounds as calcium channel blockers |
| 05/15/2013 | EP2590649A1 Process for the synthesis of substituted morphinans |
| 05/15/2013 | CN103108875A Nitrogenated aromatic compound, organic semiconductor material, and organic electronic device |
| 05/15/2013 | CN103102389A Sulfur compounds as inhibitors of Hepatitis C virus NS3 serine protease |
| 05/15/2013 | CN103102359A Pyrimidine compounds and application thereof |
| 05/15/2013 | CN103102352A Tyrosine kinase inhibitor indolinone derivative |
| 05/15/2013 | CN103102344A Aminoquinazoline derivative, salts thereof and application method |
| 05/15/2013 | CN103102342A Aminoquinazoline derivative, salts thereof and application method |
| 05/15/2013 | CN103102304A Preparation method of N-sulfonyl substituted tetrahydroisoquinoline derivatives |